Pandemic Timeline

President Trump Signs Right to Try Act Into Law

An eligible investigational drug is an investigational drug:

  • For which a Phase 1 clinical trial has been completed
  • That has not been approved or licensed by the FDA for any use
  • For which an application has been filed with the FDA or is under investigation in a clinical trial that is intended to form the primary basis of a claim of effectiveness in support of FDA approval and is the subject of an active investigational new drug application submitted to the FDA
  • Whose active development or production is ongoing, and that has not been discontinued by the manufacturer or placed on clinical hold by the FDA

— FDA

And there you have it.  In a strange twist of fate, “right to try” does not apply to hydroxychloroquine and ivermectin because they are already approved and licensed.  But COVID-19 patients should not need to cite the Right to Try Act.  Hydroxychloroquine and ivermectin may not be specifically approved for use in treating COVID-19, but they don’t need to be.  Doctors can utilize the FDA’s off-label policy to prescribe hydroxychloroquine and ivermectin to COVID-19 patients as they see fit.

Sources:

Related:

Comments are closed.